Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04274933
Status:
TERMINATED
Last Update Posted:
2020-10-29
First Post:
2020-02-17
Brief Title:
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK46 Inhibitor Therapy
Sponsor:
AbbVie
Organization:
AbbVie